Share!
The World Health Organisation, WHO has acknowledged Nigeria’s readiness to be part of the global solidarity trial of the vaccines being developed to combat the dreaded coronavirus pandemic.
The officer in charge of the global health agency in Nigeria, Fiona Braka, who spoke at the joint national briefing of the Presidential Task Force PTF on COVID-19 on Friday, said efforts are underway to start the process in the country.
Braka stated: “Nigeria has also expressed interest to be part of this solidarity trial and efforts are underway to start the process in Nigeria too.
“Together with global health actors and partners, over the past week, WHO launched the access to COVID-19 tools ACT accelerator, a global collaboration to accelerate development for equitable access to new COVID-19 diagnostics, therapeutics and vaccines.
“We have a total of 89 vaccines that are in development globally, including seven in clinical evaluation and several therapeutics are in clinical trials. WHO is committed to ensuring that as medicines and vaccines are developed, they are shared equitably with all countries and people.
“We do have the solidarity trial which is an international clinical trial to help find an effective treatment for COVID-19, launched by the WHO and partners. More than 100 countries have joined the solidarity trial and to date, over 1,200 patients have been randomized from the first five countries to evaluate the safety and efficacy of full drug and drug combinations.”
According to Nigeria Centre for Disease Control, NCDC, a total of 2170 confirmed cases of #COVID19 have been recorded in Nigeria, with 351 discharged and 68 deaths.
